2-Isopropoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACTPJB907
CAS No. :
1375303-04-0
Molecular Formula :
C15H24BNO3
Molecular Weight :
277.17

IUPAC Name:2-isopropoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-Isopropoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$181.00Login to see priceInquiryInquiry
1g95%$347.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Isopropoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name2-isopropoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD16996660
Molecular FormulaC15H24BNO3
Molecular Weight277.17
SMILESCC1(C)C(C)(C)OB(C2=CN=C(OC(C)C)C(C)=C2)O1
InChI KeyCJLOTPDZTPQXJE-UHFFFAOYSA-N
Synonym2-Isoproxy-3-methylpyridine-5-boronic acid pinacol ester;Pyridine, 3-methyl-2-(1-methylethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1375303-04-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTPJB907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTPJB907 route product structure diagram
    ACTPJB9071375303-04-0
Inquiry

2. ACTPJB907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTPJB907 route product structure diagram
    ACTPJB9071375303-04-0
Inquiry

Comments (0)